Biomarker Technologies (BMKGENE) USA Inc.

Biomarker Technologies (BMKGENE), founded in 2009, is a leading genomics service provider specializing in high-throughput sequencing and bioinformatics. With over 16 years of continuous innovation, 60+ national invention patents, and 200+ software copyrights, BMKGENE delivers comprehensive multi-omics solutions across genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and spatial transcriptomics. Supported by its proprietary BMKMANU S3000 spatial transcriptome technology and BMKCloud bioinformatics platform, BMKGENE provides reliable, end-to-end research services for global partners across 84 regions worldwide.

Product Brochure - https://cdmcd.co/GwY5AA
Eukaryotic mRNA Sequencing Flyer - https://cdmcd.co/JQgwAj
BMKMANU S300 Spatial Transcriptomics Flyer - https://cdmcd.co/Kp3dkB
Plant and Animal WGS Flyer - https://cdmcd.co/6vqkA7
T2T Genome Assembly Ultra Long Sequencing Flyer - https://cdmcd.co/7bvMMz